Evonile Pharma Approves Rights Issue of Up to ₹9,000 Million
Novartis India Ltd · Outcome · 05 Nov 2026, 12:45 am
Evonile Pharma Approves Rights Issue of Up to ₹9,000 Million Evonile Pharma Limited (formerly Novartis India Limited) approved the issuance of partly paid-up equity shares via a rights issue for up to ₹9,000 million. In its board meeting on 4th Nov'26, following prior approval on 8th Oct'26, the board cleared the payment schedule, proceed utilization, and the Letter of Offer for regulatory filing with BSE and SEBI. The Rights Issue Committee has been authorized to determine final terms, including the issue price, entitlement ratio, and record date.
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. · 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. · 06 Nov 2026
- Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026. · 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 · 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. · 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
- Submission of Investor Presentation for the Earnings Call scheduled on Wednesday, November 04, 2026. · 04 Nov 2026
